Skip to main content
The Pleryon team visited the lab of Lawrence Bonassar (center, in blazer) in 2024 to discuss the polymer technology and its potential application.

For more than a decade, David Putnam and Lawrence Bonassar have been trying to build a better molecular yarn. 

The two Cornell engineers set out to recreate lubricin, a slippery glycoprotein that keeps healthy knees, hips and shoulders gliding smoothly against each other for a lifetime. When joints are injured or aged, lubricin production drops, friction rises and cartilage begins to wear away, a process that can end in osteoarthritis, a disease affecting more than 32 million adults in the United States.

Now their discovery of a lubricin-inspired polymer has not only resulted in a start-up co-founded by one of their doctoral students but is also entering into two separate first-in-human trials. The team aims to give patients a synthetic stand-in for a natural lubricant when the body stops making enough on its own. 

The human trials in Australia will test the synthetic lubricin to treat osteoarthritis in knees, and trials in Canada will test it as a remedy for dry eye disease. If successful, the innovations could become viable treatment options for sufferers.

Read the story here.